FindTrial
Sign In

studying to role of urinary neutrophil associated gelatinase biomarker as an early predictor of acute kidney injury in patients treated with antibiotic Colistin

ROLE OF URINARY NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN AS EARLY BIOMARKER OF ACUTE KIDNEY INJURY IN PATIENTS TREATED WITH COLISTIN - NGAL

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/02/012036
Enrollment
50
Registered
2018-02-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- critically ill patients

Interventions

None listed

Sponsors

All India Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: all patients with age 18 years or more who are planned for colistin therapy

Exclusion criteria

Exclusion criteria: 1.Refusal of consent 2.History of chronic renal disease 3.Acute kidney injury features accordingg to RIFLE criteria 4.Recent contrast dye exposure(within 5 days)

Design outcomes

Primary

MeasureTime frame
1.To study pattern of changes in urinary neutrophil gelatinase associated lipocalin after administration of colistin 2.To compare serum creatinine and urinary neutrophil gelatinase associated lipocalin levels for prediction of acute kidney injury in patientsTimepoint: At completion recruitment—

Secondary

MeasureTime frame
1.To identify factors associated for colistin induced Acute kidney injuryTimepoint: At completion of recruitment—

Countries

India

Contacts

Public ContactUjwal Dhundi

All India Institute of Medical Sciences, New Delhi

drujwaldhundi@rediffmail.com9867333545

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026